Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

1 tablet contains:

Active substance: Hydroxyethyldimethyldihydropyrimidine 0.2500 g.

Excipients: calcium stearate - 0.0009 g, potato starch - 0.0446 g, talcum - 0.0045 g.

Description:
Tablets from white with a creamy shade to light pink with a creamy shade of color with impregnations of a more intense shade, round, flat-cylindrical shape with a facet and a risk.
Pharmacotherapeutic group:Reparation of tissue stimulant
ATX: & nbsp
  • Tetanus preparations
  • Pharmacodynamics:Ximedon accelerates the processes of tissue regeneration and shortens the healing time of the burn surface, improves the engraftment of skin grafts with autodermoplasty. Promotes the normalization of the relationship between the content of fibrinogen in the blood and its fibrinolytic activity, improves regional blood circulation. Normalizes the immune system, increases the phagocytic activity of T-lymphocytes and nonspecific resistance of the body. Stimulates erythro- and leukopoiesis, cellular and humoral defense factors, has anti-inflammatory and antimicrobial effects.
    Pharmacokinetics:
    When oral hydroxyethyl dimethyldihydropyrimidine is taken rapidly, it is absorbed within 0.5-1 h; the maximum concentration of the drug in the blood serum is achieved after 1.7 hours.The half-life of the drug is 5.5 hours. As a result of the low percentage of binding to serum albumin (9%) and the lack of biotransformation in the body, the drug does not have a competitive effect with other medications.
    Indications:In the complex therapy of the following diseases: deep and superficial burns (preparation of patients for autodermoplasty), long-term non-healing wounds, trophic ulcers, peptic ulcer of stomach and duodenum, bedsores, frostbites, purulent inflammatory diseases of soft tissues and bones, chronic osteomyelitis, streptococcal infections (angina, erysipelas), microbial eczema, psoriasis, viral hepatitis, pulmonary tuberculosis, pneumonia, chronic bronchitis, chronic cystic sinusitis, salmonellosis, rheumatism, deep thrombophlebitis veins of the lower extremities, pre- and postoperative periods for the prevention of purulent-inflammatory complications of postoperative wounds, especially in patients with a high risk of insufficiency of the abdominal wall joints (anemia, diabetes mellitus, etc.) and gastrointestinal tract.
    Contraindications:Hypersensitivity. Leukemia (acute and chronic), erythremia, children under 18 years.
    Carefully:Patients with diabetes should be more likely to determine glucose tolerance, due to the possible decrease in the need for insulin.
    Pregnancy and lactation:

    The use of the drug is indicated only in cases where the intended use for the mother exceeds the potential risk to the fetus.

    During the treatment period, it is necessary to resolve the issue of stopping breastfeeding.

    Dosing and Administration:

    Use inside before eating.

    With deep and superficial burns (preparation of patients for autodermoplasty) - 0.5 g 3 times a day for 20 days. When carrying out skin-plastic operations, the drug is prescribed before and after the operation for 10 days.

    With long-term non-healing wounds, trophic ulcers, bedsores - 0.5 g 3 times a day for 25-30 days.

    With peptic ulcer of the stomach and duodenum - 0.5 g 2 times a day for 12 days.

    With frostbites - 0.25-0.5 g 3-4 times a day for 2-5 weeks.

    When purulent-inflammatory diseases of soft tissues and bones - for 0.5 g 4 times a day for 10-30 days.

    In chronic osteomyelitis - before and after the operation, 0.5 g 4 times a day for 20-25 days. Repeated courses of treatment are carried out after 6 months for 1.5 years.

    With angina, erysipelas - 0.5 g 3 times a day for 7-10 days.

    With microbial eczema - 0.5 g 3 times a day for 10 days.

    With psoriasis - 0.5 g 3 times a day for 2-3 weeks.

    With viral hepatitis B and C, 0.5 g 3 times a day for 10 days.

    With pulmonary tuberculosis - 0.5 g 4 times a day for 2 months.

    For pneumonia and chronic bronchitis - for 0.5 g 4 times a day for 18-21 days.

    In chronic cystic sinusitis - 0.25-0.5 g 4 times a day for 1 month.

    With salmonellosis - 0.5 g 3 times a day for 7 days.

    With rheumatism - 0.5 g 3 times a day for 3-4 weeks.

    In pre- and postoperative periods to prevent purulent inflammatory complications of postoperative wounds, especially in patients with a high risk of insolvency of the abdominal wall joints (anemia, diabetes mellitus, etc.) and gastrointestinal tract - 0.5 g 4 times a day for 10 -20 days (from the first day after the operation or in the preoperative period 3-5 days and further from the first day after the operation).

    Side effects:Possible - dyspepsia, allergic reactions.
    Overdose:Due to the low toxicity and wide latitude of the therapeutic effect of Xymedon, no cases of toxic manifestations were observed.
    Interaction:

    The incompatibility of Xymedon with any medications has not been identified.

    You can combine with anabolic steroids, chemical and biological antiseptics.

    Effect on the ability to drive transp. cf. and fur:The drug does not affect the ability to drive vehicles, and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
    Form release / dosage:
    Tablets 250 mg.
    Packaging:
    For 10 tablets in a contour mesh package or 50 tablets in cans of orange glass. 2, 5, 10 contour mesh packages or a jar along with the instructions for use are placed in a pack of cardboard.
    Storage conditions:In a dry, the dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children.
    Shelf life:2 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LS-000045
    Date of registration:03.08.2010 / 20.10.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:TATHIMFARMPREPARATY, JSC TATHIMFARMPREPARATY, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp06.02.2018
    Illustrated instructions
      Instructions
      Up